免播放器av少妇影院-欧美xxxxbbbb在线播放-中文字幕在线视频播放-久久久久久国产精品免费免|www.jhygf.com

贏創提醒客戶于正規銷售渠道購買蛋氨酸產品

來源:    作者:    時間: 2018-09-17

 

日前在中國市場發現假冒贏創蛋氨酸的產品,贏創工業集團提醒廣大消費者通過官方渠道購買產品。

最近有顧客在某電商平臺購買了兩袋metaMINOâ,后懷疑是假貨并聯系了贏創。公司對該產品進行核查化驗后確認為假貨,其蛋氨酸含量低于0.5%,其余95%以上為灰分。

“我們多年來一直是飼料添加劑行業的領先供應商,客戶認可和信任我們的品牌。”贏創動物營養北亞區副總裁Torben Madsen博士說。“銷售假貨不僅僅是非法和欺騙行為,更給養殖戶以及養殖動物帶來風險。由于不知道使用的產品究竟是什么,可能會導致無法獲得預期的動物生產表現,甚至會危害到動物的健康和福利。”

為防止客戶遭受損失,建議通過以下三個官方渠道購買贏創產品:

1. 贏創動物營養業務線銷售團隊

2. 贏創動物營養業務線授權經銷商,咨詢電話400-068-1212

3. 贏創阿里巴巴官方旗艦店 :evonik.1688.com。 

贏創對于所有假冒產品零容忍,并將起訴生產假冒贏創產品的公司和個人。

欲了解更多信息,請訪問www.evonik.com/animals-nutrition

 

about Evonik

Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-orientated innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world with more than 36,000 employees. In fiscal 2017, the enterprise generated sales of €14.4 billion and an operating profit (adjusted EBITDA) of €2.36 billion.

about Nutrition & Care

The Nutrition & Care segment is led by Evonik Nutrition & Care GmbH and contributes to fulfilling basic human needs. That includes applications for everyday consumer goods as well as animal nutrition and health care. This segment employed about 8,250 employees, and generated sales of around €4.5 billion in 2017.

Disclaimer

In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.

 

EVO/029/18